Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Investigative Ophthalmology & Visual Science|November 6, 1998
Retrovirus-mediated gene transfer to photocoagulation-induced choroidal neovascular membranesT Murata, M Hangai, T Ishibashi, et al.Human Gene Therapy|May 1, 1996
Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferative vitreoretinopathyH Kimura, T Sakamoto, J A Cardillo, et al.Human Gene Therapy|April 29, 1998
Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cellsL Yang, Y Chiang, H J Lenz, et al.International Journal of Molecular Medicine|November 18, 2000
Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: efficacy in an animal model of experimental colitisF L Hall, A Kaiser, L Liu, et al.Biochemical and Biophysical Research Communications|October 15, 1984
Ketomethyldipeptides I. A new class of angiotensin converting enzyme inhibitorsS Natarajan, E M Gordon, E F Sabo, et al.AJNR. American Journal of Neuroradiology|November 3, 2007
Corticospinal tract abnormalities are associated with weakness in multiple sclerosisD S Reich, K M Zackowski, E M Gordon-Lipkin, et al.Journal of Medicinal Chemistry|April 12, 1996
Versatile approach to encoding combinatorial organic syntheses using chemically robust secondary amine tagsZ J Ni, D Maclean, C P Holmes, et al.International Journal of Molecular Medicine|September 20, 2001
Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptorsR Masood, E M Gordon, M D Whitley, et al.Blood|May 1, 1994
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study GroupG L Bray, E D Gomperts, S Courter, et al.Medical and Pediatric Oncology|January 1, 1982
Bone marrow transplantation with high-dose cytosine arabinosideR H Herzig, H M Lazarus, J Graham-Pole, et al.Pageof 11